CapsoVision (CV) Cost of Revenue (2024 - 2025)

CapsoVision's (CV) quarterly Cost of Revenue came in at $800000.0 in Q4 2025, down 55.53% year-on-year from $1.8 million in Q4 2024, and down 54.88% quarter-over-quarter from $1.8 million in Q3 2025.

CapsoVision (CV) Cost of Revenue (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Cost of Revenue across 2 years of filings, most recently posting $800000.0 for Q4 2025.

  • Cost of Revenue for Q4 2025 came in at $800000.0, down 55.53% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.9 million (changed N/A YoY), and the FY2025 annual result was $6.4 million, down 8.41% from the prior year.
  • Cost of Revenue came in at $800000.0 for Q4 2025 at CapsoVision, down from $1.8 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.8 million in Q4 2024 to a low of $800000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 4.89 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 2.21 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 3.26 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.59 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 362.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.51 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 441.60 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 481.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 891.20 Mn
10 CapsoVision 161.82 Mn 151.71 Mn 1.95 Mn 800,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 800,000.00
Dec 31, 2025 800,000.00
Sep 30, 2025 1.77 Mn
Sep 30, 2025 1.77 Mn
Jun 30, 2025 1.50 Mn
Jun 30, 2025 1.50 Mn
Dec 31, 2024 1.80 Mn
Dec 31, 2024 1.80 Mn
Sep 30, 2024 1.31 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.78 Mn
Jun 30, 2024 1.78 Mn